2m 2m 2m 2m 2m 2m 2m
CONTEXT THERAP (CNTX)
NASDAQ
$0.50-$0.001 (-0.22%)
Price as of Aug 21, 2026 7:31 PM EDT- $45.9MMarket Cap
- -44.00%1-Year Change
- BiotechnologyIndustry
CONTEXT THERAP (CNTX)
$0.50-$0.001 (-0.22%)
CNTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.50 | ||
Change | -$0.02 (-3.77%) | ||
Open | $0.53 | ||
High | $0.55 | ||
Low | $0.50 | ||
Previous Close | $0.52 | ||
Volume | 1,747,422 | ||
30-Day Average Volume | 1,954,029 | ||
1-Week Change | -4.36% | ||
1-Month Change | -20.62% | ||
1-Year Change | -44.00% | ||
3-Year Change | -50.97% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 91.9M | ||
Total Assets | $46.1M | ||
Market Cap | $45.9M | ||
Enterprise Value | $3.0M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$14.6M | ||
Free Cash Flow | -$7.0M | ||
EBIT | -$14.6M | ||
EBITDA | -$14.6M | ||
Net Working Capital | $37.9M | ||
EPS | -$0.15 | ||
Enterprise Value/EBITDA | -0 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -3 | ||
PEG | 0 | ||
Price/Free Cash Flow | -7 | ||
Price/Operating Cash Flow | -7 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue